HomePTGX • NASDAQ
add
Protagonist Therapeutics Inc
Previous close
$25.56
Day range
$24.78 - $26.32
Year range
$13.72 - $33.34
Market cap
1.49B USD
Avg Volume
522.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 60.00M | — |
Operating expense | 36.95M | 1.19% |
Net income | 27.34M | 179.94% |
Net profit margin | 45.56 | — |
Earnings per share | 0.44 | 163.77% |
EBITDA | 23.30M | 164.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 341.62M | 43.93% |
Total assets | 357.95M | 44.38% |
Total liabilities | 21.27M | -34.18% |
Total equity | 336.68M | — |
Shares outstanding | 58.27M | — |
Price to book | 4.38 | — |
Return on assets | 16.75% | — |
Return on capital | 17.96% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 27.34M | 179.94% |
Cash from operations | 16.96M | 153.61% |
Cash from investing | -61.29M | -1,657.48% |
Cash from financing | 527.00K | -4.70% |
Net change in cash | -43.80M | -61.79% |
Free cash flow | 6.06M | 132.33% |
About
Founded
2006
Headquarters
Website
Employees
112